Jan 30, 2023
Patients with chronic lymphocytic leukemia (CLL) infected with COVID-19 during the most recent...
PW QUIZ
Post-transplant cyclophosphamide/tacrolimus/mycophenolate mofetil outperformed...
Intensive chemotherapy, in advance of allogeneic hematopoietic cell transplantation (allo-HCT),...
The 5-year follow-up data of the CAPTIVATE study demonstrated that first-line ibrutinib plus...
High-dose methotrexate was not associated with a reduction in the risk for CNS relapse compared...
Triplet therapy of azacitidine, venetoclax, and magrolimab was safe as first-line therapy in...
FSS are industry-supported, CME-certified symposia. These sessions are not part of the official...
The ASH Foundation Run & Walk will start and finish on Convention Center Boulevard and...
Key Protocols: Vaccination will be required for all in-person meeting attendees. ASH is...
EXPLORE MORE
Friday, December 9th 7:00 a.m.– 6:00 p.m. Registration open (for in-person participants) 7:00...
Patients with aggressive hematological malignancies and second primary malignancies can develop...
For a study, researchers sought to determine if ibrutinib combined with fludarabine,...
FIRE is a noninterventional, multicenter observational trial of patients in France receiving...
With the development of cutting-edge drugs like Ibr, the treatment landscape for CLL/SLL has...
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.